Thursday, November 30, 2023 - 5pm – Auditoire Maisin

Juliette LAGREULA - Translational Research from Experimental and Clinical Pharmacology to Treatment Optimization – CLIP and PMGK

Optimising antipsychotic prescribing in schizophrenia - Understanding the factors contributing to antipsychotic polypharmacy and personalising treatment to improve pharmacotherapy

Promotors: Prof. Olivia Dalleur and Prof. Laure Elens

Related references:

• Lagreula J, de Timary T, Elens L, Dalleur O. Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation. Therapeutic advances in psychopharmacology. 2022; 12:1-12
• Lagreula J, Dagenais-Beaulé V, de Timary P, Elens L, Dalleur O. Prescribing and deprescribing trends in schizophrenia: an overview of inpatients in Belgium and in the Canadian province of Québec. Basic & Clinical Pharmacology & Toxicology. 2023;1–12.
• Lagreula J*, Ferraiolo M*, de Timary T, Delatte B, Elens L, Hermans E, Dalleur O. Impact of a caffeine restriction policy on inpatients with schizophrenia: a pre-post comparison using electronic health records. Journal of clinical psychopharmacology. 2023, 43:167-170 *The first two authors equally contributed to this work.
• Lagreula J, Lorant V, Dalleur O. Assessing the professional social capital of psychiatrists: development of the Resource Generator for Psychiatrists (RG-Psy). Submitted

Info: olivia.dalleur@uclouvain.be